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Abstract 
Background: Depression among college students is an escalating problem and could have serious consequences such as suicide. 
There has been an increase in use of antidepressants on college campuses in United States. However, an in depth understanding of 
this phenomenon from the college student’s perspective is lacking in the literature. Objective: This study examined college students’ 
experiences and treatment decision making during their depression treatment. Methods: A longitudinal, phenomenological research 
methodology was completed. The participants were nine students who were taking antidepressants for diagnosis of depression. 
Recruitment was done via brochures placed at University bulletin boards, and a mental health clinic. Three audio taped, unstructured 
interviews were conducted with each participant over four months. The central question asked was: What has the experience of 
treating depression been for you? Analysis of text was done using Van Manen’s lifeworld existentials of lived body, lived time, lived 
relation and lived space as the organizing framework. Results: Thirteen themes were identified within the four lifeworlds. The results 
showed that lived relation with providers was important for college students’ decision to both initiate and continue antidepressant 
use. Students’ role was defined in conjunction with provider’s role by them as wanting to be a ‘player’ in their treatment decisions 
and needing to be ‘acknowledged’ as such by their providers. Conclusions: Overall, the underlying essential theme of ‘autonomy’ was 
portrayed by the students’ experiential accounts of their depression treatment and treatment decision making.  
 
 
Introduction 
Between 1988 and 2003, the likelihood of a college student 
suffering from depression doubled and suicidal ideation 
tripled.
1 Anti-depressant use by all Americans has increased 
by almost 400 percent between 1988 and 2008 and 
correspondingly, the use of antidepressants on college 
campuses in United States and the utilization of campus 
counseling centers increased as well.
2-5 According to the Fall 
2009 American College Health Association, National College 
Health Assessment,
6 college students reported experiencing 
the following in the last 12 months:  
  Felt overwhelmed by all you had to do (85%) 
  Felt exhausted (not from physical activity) (80%) 
  Felt very sad (60%) 
  Felt very lonely (56%) 
  Felt overwhelming anxiety (47%) 
  Felt things were hopeless (46%) 
  Felt overwhelming anger (37%) 
  Felt so depressed that it was difficult to function 
(30%) 
  Diagnosed or treated by a professional for 
depression (9%) 
  Seriously considered suicide (6%) 
  Intentionally cut, burned, bruised, or otherwise 
injured yourself (5%) 
  Attempted suicide (1%) 
Depression among college students is an escalating problem 
and has now surpassed substance abuse and alcohol use as a 
cause for concern on college campuses.
1  This is a problem 
not only for college students themselves, but their families, 
friends, as well as college administrators, to take note of and 
to stop the problem from growing further. In the National Co-
morbidity Survey Replication study by Kessler et al.,
7 life time 
prevalence of major depressive disorder was found to be 
16.6% which was higher than alcohol abuse and substance 
abuse disorder and second only to the entire class of anxiety 
disorders. The World Health Organization has categorized 
depression as among the most disabling disorders in the 
world, estimated to affect nearly 340 million people 
worldwide.
8 
 
The purpose of this paper was to gain insights from college 
students’ perspectives to help develop better depression 
treatment and as a result better caring of depressed 
students’ needs. Secondly, this specific group of patients has 
not been studied extensively with respect to their depression 
medication treatment experiences. Using phenomenological 
inquiry, this study investigated college students’ experiences 
of depression medication treatment within the decision 
making context as described by the study respondents. This 
information would be useful for clinicians to help them be 
better informed regarding this particular group of patients’ Original Research  PHARMACY PRACTICE 
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perspectives and experiences and hence individualize care 
and treatment of depression.  
 
Study Context and Literature Review 
Overall, there is so much variation in the treatment of 
depression and its problems, that it cannot be completely 
understood at the system level. Hence there is a need to 
examine a certain population at the patient level to obtain a 
deeper “understanding” and uncover issues related to this 
problem. To be able to study in depth and understand one 
‘slice’ of this wide-ranging problem, we decided to focus on a 
specific group of patients, that is, ‘college students that 
received antidepressant medication treatment for 
depression’. While some studies have been conducted to 
examine patients’ experience of depression
9,10 relatively few 
studies have specifically examined medication taking or the 
overall treatment experience of patients being treated for 
depression. A brief overview of literature we found is 
presented next.   
 
Knudsen
11
  examined SSRI (selective serotonin reuptake 
inhibitor) use among younger women in Denmark using the 
grounded theory method. The author reported that self 
concept of the women in the study changed during their 
career as antidepressant users wherein they evaluated 
themselves from what they believed was the perspective of 
the society and their concept of self was closely related to 
how they functioned in their everyday life.  
 
Another qualitative study that examined patient’s views and 
experiences of taking antidepressants found that patients 
initially were ambivalent about taking antidepressants, but 
that their attitudes towards antidepressants changed over 
time in response to experience of treatment.
12 The sample 
for this study ranged in age from 18-69 years and not all of 
the study participants were taking antidepressants. The 
authors mentioned that there was a wide range of responses 
to antidepressant medications which might be attributed to 
the large variation in type of study participants.  
 
Karp
13 explored the symbolic meanings attached to taking 
antidepressant medications via in-depth interviews of a wide 
range of persons, using the grounded theory method. The 
study participants varied considerably in age, race and 
occupation providing a broader perspective on 
antidepressant use. The results of his study showed that an 
individual’s changing response to psychiatric medications can 
be described as a socialization process, the four stages of 
which were described as resistance, trial commitment, 
conversion and disenchantment. The study extended the 
literature on patients’ perspectives of psychiatric drug use by 
examining a specific class of drugs – tri-cyclic antidepressants.  
Other approaches, such as claims data analysis
14 and self-
administered surveys
15,16 
 
have been used for identifying drug 
related, disease related, and patient related demographic 
factors associated with aspects of depression treatment, 
particularly medication discontinuation. To understand 
medication discontinuation more deeply, Wang et al.
16
 
reported findings from a focused approach in which they 
utilized a survey instrument to understand the initiation and 
continuation of treatment with regards to mentally ill 
patients. However, their study did not specifically study 
depressed patients.  
 
In addition, some studies examined several aspects of 
treatment decision making for depressed patients and how 
patient-provider interaction or the patient-provider 
relationship affected outcomes of depression care.
17,18,19 
 
For 
these, however, we found no study that had a specific focus 
on college students.  
 
Our study built upon existing research in the area of 
depression treatment by providing in depth information on 
college students’ experience of treatment of depression and 
their treatment decision making, described in combination 
with the college students’ narrative of their antidepressant 
medication experience. The objective of this study was to 
describe college students’ experiences as they underwent 
treatment for depression. The specific aims of the study were 
to examine:  
1.  the decision-making processes involved in 
depression treatment, as described by the 
respondents.  
2.  respondents’ view of their role in their treatment 
decisions.  
3.  respondents’ view of their provider’s role in their 
treatment decisions.  
 
Methods 
Phenomenology (the study of lived experience) was the 
specific research methodology used for this study. Study 
participants were college students taking antidepressants for 
diagnosis of depression. Since this was a longitudinal study 
requiring two follow ups over time, the sample size of up to 
ten participants was decided as optimal for this study to allow 
for loss to follow up.
20 Only one student was lost to follow up. 
Recruitment was done via flyers and brochures placed at 
University bulletin boards, and mental health clinic. Contact 
information for the researcher was provided on the 
brochures for interested persons to call and decide on 
convenient interview times and location. In this study, all nine 
participants voluntarily met at the researcher’s office for the 
interview process. Participant selection was based on the 
following inclusion and exclusion criteria:  Original Research  PHARMACY PRACTICE 
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Inclusion Criteria:  
  Adults (18 years and above) enrolled at the 
University of Minnesota  
  Diagnosed with depression  
  Taking current antidepressant for 6-12 weeks  
  Self-administer antidepressant medication  
  Willing to participate as indicated by signed 
informed consent 
 
Exclusion Criteria:  
  Non-English speaking  
  Taking antidepressants for conditions other than 
depression  
  Hospitalized patients  
 
Before the main study, a pilot interview along with one follow 
up was conducted with a college student who was taking 
medication for treatment of depression. This was done as a 
method pilot that helped the researcher gain knowledge 
about the research area as well as become familiar with the 
interview situation and to come up with appropriate probes 
or follow up questions to ask of interviewees during the main 
study. One main outcome of this was the researcher’s 
decision to not use member checking (the restating of 
information and asking the participant to comment on its 
accuracy) for the main study since the interviewee admitted 
to being upset when all her treatment experience was 
presented to her as a whole. This could have served as a 
reminder of some of her unfortunate experiences. The other 
usefulness of doing a method pilot was in refining some of 
the probe questions based on the pilot interviews.  
For the main study, in order to capture the narrative, the 
students were asked to reflect on their experience and relate 
their experience in the format of a story.
21 To help the 
participants prepare for the interview they were given a few 
examples of questions to think about (e.g. what happened in 
your first encounter with the physician?).   
 
Approval for this study was obtained from the University’s 
Institutional Review Board. An informed consent form for the 
study was reviewed and signed by each participant before the 
first interview. Three audio taped, unstructured interviews 
over a period of four months were conducted with each 
participant. First interview was conducted at 6-12 weeks of 
current treatment, second interview was done at six weeks 
after the first interview and last interview was done at four 
months (16 weeks) after first interview. The central question 
asked of the participants was: Tell me, what has the 
experience of treating depression been for you? Probes or 
follow up questions were used selectively.
22
 Field notes also 
were recorded. Participants were asked information on 
demographic, medication history and contact information. 
They were given a total of $70 in University Bookstore gift 
certificates in return for their participation in three 
interviews.  
 
The audio taped interviews were transcribed verbatim. The 
text of all transcripts was coded using the thematic format 
described by Van Manen.
23 Three coding approaches used to 
uncover the thematic aspects of the phenomenological text 
were (1) holistic, (2) selective and (3) detailed (line by line) 
approaches.
23  
 
For the resultant coded text, the following two-phased 
analysis approach was used:  
 
Phase I - Organizing & Reflecting on Text Using Lifeworld 
Existentials  
In this phase of analysis, Van Manen’s Lifeworld Existentials- 
lived space, lived body, lived time, and lived relation were 
used to guide reflection on the study text. These are themes 
that pervade the life world of every human being regardless 
of their historical, cultural or social connectedness although 
not in the same modality for every person. The Lifeworld 
Existentials
23 are briefly described below:  
 
Lived Space is felt space and referred to as the landscape in 
which humans move or find themselves at home. How a body 
inhabits a space affects the way that persons feel about 
themselves, for example, vulnerable in a strange place and 
comforted in a familiar place.  
 
Lived Body (corporeality) describes the body not merely as 
an object in the world but rather one’s being-in-the-world by 
which one perceives, values and judges.  
 
Lived Time (temporality) describes one’s temporal way of 
being-in-the-world. It refers to subjective time as opposed to 
clock time. The temporal dimensions of past, present and 
future constitute the horizons of a person’s landscape.  
 
Lived Relation (relationality) denotes the relationships 
humans maintain with others in the interpersonal space they 
share with them.  
 
Phase II - Deriving the Essential Theme Using Imaginative 
Variation 
This phase of analysis involved isolating and differentiating 
those themes that were essential to the experience of 
depression treatment from themes that were incidental. The 
essence of the experience is derived through the process of 
question posing and reflecting on the text and writing and 
rewriting about the common experience that emerges from 
the four lifeworld domains. The Essential Theme was Original Research  PHARMACY PRACTICE 
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determined by use of free imaginative variation technique.
23 
This technique used to derive the essential theme was 
determined by asking the following questions of the text: 
Does this phenomenon remain the same if we imaginatively 
change or delete this theme from the phenomenon? Does the 
phenomenon without this theme lose its fundamental 
meaning? 
 
The researcher reflected on the individual responses of the 
participants, the whole of each participant’s experience, and 
similarities and differences between participants, in order to 
arrive at themes that most appropriately and accurately 
characterized the phenomenon under study. The researcher 
also conducted “hermeneutic conversations” with experts in 
qualitative methods. During these conversations, themes’ 
orientation to the phenomenon and the fit of the themes 
with the text was verified.  
 
Considerations of Rigor  
The treatment experience in this study was obtained as lived 
by the college students and not as either by the researcher or 
anyone else. To help evaluate the rigor with which the study 
was conducted, the criteria of Credibility, Fittingness and 
Auditability
24 were employed at every stage of the study. 
These criteria for rigor are described next. 
 
Credibility (similar to internal validity in quantitative 
research) measures how vivid and faithful are the 
descriptions of the phenomenon. In this study, the two 
primary ways that credibility was achieved was that first, the 
analysis procedures were reviewed in detail by one of the co-
authors (CPM) who is a qualitative research expert, in order 
to prevent researcher bias and selective inattention and 
secondly, by the primary researcher (RLS) providing rich 
excerpts from the transcripts in the results.  
 
Fittingness (similar to external validity in quantitative 
research) measures how well the working hypothesis or 
proposition fit into a context other than the one from which it 
was generated. This is done by comparing and contrasting the 
findings of this study to what is already known about this 
topic.  
 
Auditability (similar to reliability in quantitative research) 
refers to the ability of another investigator to follow the 
decision or audit trail. Journaling allowed the investigators 
and readers to retrace the trail of the analysis.
25  
 
Results 
The results of the study are described in terms of 1) 
descriptive information; 2) themes identified using the 
lifeworld existential; and 3) the Essential Theme. Descriptive 
information about the study participants is given in Appendix 
I.  
 
Regarding Lifeworld Existentials
23, thirteen themes emerged. 
Of these, four related to lived body, four to lived time, three 
to lived relation, and two to lived space. Each of the 13 
themes is summarized in Appendix II.  Appendix III contains 
text examples of each lifeworld and a summary of each 
lifeworld is given next. 
 
Lived Body: The students described their role in their 
treatment decision making as that of a ‘player’. They 
described different bodily effects of the antidepressants 
at initiation, continuation and at discontinuation. Also, 
students were quite proactive in helping treat their 
depression using other non-drug steps in order to 
improve their emotional and physical well being.  
 
Lived Time: Students chose to take antidepressants over 
seeking counseling or therapy since they perceived a 
‘lack of time.’ Students did not foresee discontinuing 
their antidepressants until the time that they were not 
stressed by school and other life’s demands, as stated by 
one of the students “Till I feel my life isn’t it as chaotic”. 
Overall, they did not have much trouble adhering to their 
daily medication regimen. Over time most students 
developed ‘patience’ for waiting for the effect of the 
antidepressant that they were taking.  
 
Lived Relation: The students’ described their provider as 
someone who would ‘acknowledge them’ and ‘involve 
them’ in their treatment decision making. The students 
in this study perceived psychologists to be helpful only in 
case of a precipitating event, if at all. Other lived 
relations that the students had with their family 
members, partners and their friends were described as 
being helpful in their depression treatment. Both were 
described as being ‘supportive’ but not playing a major 
role in the treatment decision making of these students.  
 
Lived Space: The students proactively created a ‘new 
lived space’ during their treatment of depression to 
reduce the stigma associated with it. Also, students 
perceived a ‘change in their existing space’ wherein one 
change was feeling less isolated as a result of knowing 
that there were others who felt like them.  
 
The Essential Theme - Autonomy driving college students’ 
depression treatment  
On examining the lifeworld themes of the students’ 
narratives using further reflection, analysis and writing and 
rewriting, the essential theme was revealed. ‘Autonomy’ was Original Research  PHARMACY PRACTICE 
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found to be the essential theme since it was evident in each 
lifeworld of the students. A text example for the Essential 
Theme is given in Appendix IV. The underlying essential 
theme of ‘autonomy’ was portrayed by the study participants 
experiential accounts of their depression treatment and 
when they described their role in treatment decision making.  
 
Autonomy was seen through the ‘relations’ they had with 
their family, friends and health care providers. Also, evident 
in how they referred to their ‘body’ or ‘being-in-the-world’ 
and how their perception of such autonomy changed over 
‘time’. Regarding lived ‘space’, the students strove for 
autonomy by making efforts to change their immediate lived 
environment through ‘being there’ for depressed others who 
were in need of help and by avoiding situations that were 
‘detrimental to their depression treatment’. In this study, 
students described using different examples that they would 
want to be a ‘player’ in not only their depression treatment 
but any health problems that they may have since it was 
“their body and their health care.” Such cases made it more 
plausible to consider ‘autonomy’ as a theme specific to 
college students’ treatment decision making or at least 
specific to this younger age group of 18 to 30 years since 
depression treatment did not remain the only commonality.  
 
It should be noted that autonomy as described by the 
students in this study was not completely divorced from the 
provider’s role in their treatment decisions. In fact, when the 
autonomy of some students was acknowledged by their 
providers, it led to the students continuing their 
antidepressant medication. If their autonomy was ignored by 
the providers it more often than not led to antidepressant 
discontinuation. So it might be argued that it is this 
‘disconnect’ in the patients’ and providers’ perception of 
presence of autonomy that is the factor affecting the 
treatment outcomes.  
 
Difficulties and Limitations  
Study participants may have felt uncomfortable to discuss 
their experiences on tape. We allowed for ample time before 
the interview to discuss any such issues with the interviewee, 
as well as to facilitate the establishing of a relationship 
between the interviewer and interviewee. The time intervals 
between interviews were deemed short enough to reduce 
any serious memory recall issues. However this may have 
been still problematic for some respondents. This study used 
a small sample of depressed college students from one 
campus in a Midwestern university in United States, 
therefore the findings of this study should be regarded as 
specific to this sample until confirmed by research in other 
demographic or geographic settings.  
 
Discussion 
Overall, this study described the phenomenon of depression 
treatment with respect to college students. The focus was on 
describing the antidepressant use and treatment decision 
making of this group of patients to allow tailored care. Hence 
this study gave voice to college students’ depression 
treatment experiences. The different stages that the students 
go through in their depression treatment were described in 
this study and can be potentially intervened upon to better 
the antidepressant use process.  
 
Patient’s role was defined in conjunction with provider’s role 
by the college students in this study as students wanting to 
be a ‘player’ in their treatment decisions and needing to be 
‘acknowledged’ as such by their providers. It is significant that 
the sense of autonomy was underlying college students’ 
decisions regarding their depression treatment. Related to 
this essential theme of ‘autonomy’, are the findings of the 
study by Knudsen et. al.
11
  who found that the young group of 
Danish women in their study changed in their self concept 
over their career as SSRI users from being ‘distressed and 
needing help’ to having ‘problems discontinuing their 
medication.’ While in the present study, it was found that the 
college students for the most part were not against taking 
medication and also they did not feel too much conflict 
regarding continuing antidepressant treatment. In fact, most 
of the patients in this study had no problems in staying on the 
medication for extended periods of time.  
 
This finding is also different from the study by Gammel & 
Stoppard
26  where they found that ‘younger’ women in 
Canada were against taking medication and wanted to cope 
on their own as opposed to ‘older’ women. However, there 
may be a qualifier here where some respondents in the 
present study, while explicating benefits of taking 
medication, acknowledged the use of behavioral modification 
as a long term solution to their depression.  
 
Regarding other findings from this study, it was interesting to 
note that unlike other studies examining experience of 
treatment of depression
11,26 patients in this study did not 
subscribe to the biological model of depression as the only 
explanation of the disease even though they were taking 
medications to treat their depression. This could be 
attributed to an increased general awareness of other 
options that help in treating depression. Another factor could 
be that nowadays, the treatment of depression with 
medication doesn’t need to be justified by patients having to 
change their beliefs about depression. Such ‘cognitive 
dissonance’ might have been reduced or eliminated by the 
commonness of treating depression with medication in the 
present society, at least in the United States.  Original Research  PHARMACY PRACTICE 
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Also, unlike the study by Goldstein & Rosselli
27
 
some students 
in this study seemed to endorse both the biological model of 
etiology of their depression and the psychological model. This 
seemed to be the case especially in students who had more 
experience with taking antidepressants. These students could 
definitely say that they believed that the medication was 
helping with the biological aspect of their depression but that 
they would not only seek psychotherapy but also change 
their life’s situations for obtaining long term cure for the 
psychological aspect of their depression.  
 
Autonomy among Depressed College Students 
Overall, students showed complete autonomy regarding their 
relations with family and friends. This could be attributed to 
the developmental stage of the young students where they 
are most likely asserting their autonomy in every aspect of 
their lives and not just their depression treatment. The 
finding of autonomy does suggest that the provider might no 
longer need ‘to make an effort to involve patients (especially 
students)’ in their treatment decisions as may have been the 
case even a few years ago, for instance as described by 
Chewning & Sleath
28 in their discussion of the client-centered 
model. The role of the patient as being autonomous is 
becoming clearer. Now, the role of the provider might need 
to be redefined as one not encouraging patients but 
acknowledging this autonomy and working with it towards 
the goal of optimal outcomes. Considering this finding of 
autonomy in the context of the patient- provider relationship, 
the next section provides a discussion of the patient- provider 
interaction that was described in this study.  
 
Patient – Provider Interaction in Depression Treatment  
Similar to findings reported by Bultman & Svarstad
17 our 
findings showed that provider communication and 
interaction played a significant role in patients’ decision 
regarding the continuing of their medication. Some providers 
informed these students that it was common for other 
students in a similar situation as them to stay on 
antidepressants for longer periods. Such information from 
the provider made the students ‘ok’ with continuing 
medication treatment. There may also be a placebo effect in 
play here since a placebo effect has everything to do with the 
expectation of benefit. So there is a need for providers to 
make patients comfortable with talking to them first and then 
explaining clearly what are the expectations of the benefits of 
the treatment that they are offering their patients.  
 
Patients’ view of their role as a ‘player’ in their decisions, 
which increased over time, reveals an important aspect for 
providers to keep in mind since accordingly they would need 
to tailor their communication style to provide effective 
patient care. It is imperative to realize that for these college 
students there is a need to be involved in their treatment 
decisions and not be treated as people who don’t know what 
do to do and what they want. The need for being 
acknowledged is important for depressed patients; arguably 
more than any other patients.  
 
On the other hand, by the college students defining their role 
in their treatment decisions through autonomy, it may be 
that the role of their health care provider need not be made 
explicit. It could be suggested that there is no role other than 
to help, facilitate these ‘autonomous but depressed’ patients 
through their journey of treatment decision making. This 
issue of patient and provider roles in depression treatment 
decisions will be further discussed under study implications.  
 
Suggestions for Future Research  
This study, by describing the medication use process for 
depressed college students contributed to the understanding 
of antidepressant medication use. The patient’s *college 
student’s+ view was presented in this study as a beginning 
point for understanding depression treatment experience and 
decision making. The next step would be to describe 
providers’ views and experiences regarding treating 
depression. It would be useful to consider the different 
effects on patients described in this study to tailor care at the 
different stages of antidepressant use.  
 
Cultural aspects of treatment would also be interesting and 
important to study. This study ‘scratched the surface of it’, by 
including only one person’s experience of cross cultural 
differences in receiving and accepting care for depression. 
Specifically, there may be differences in aspects of the 
‘autonomy’ uncovered in this study across different cultures. 
Also, information from this study would be useful to create 
patient rated outcome measures for depression treatment 
evaluation since patients are the best resource for knowing if 
the treatment is working.  
 
Study Implications  
The implications of this study will be discussed under four 
different levels of implications beginning with the discussion 
of ‘patient- provider interface’, and then discussing 
implications for ‘pharmacy’, then implications for the ‘health 
care system and college systems’ is described followed by the 
broader ‘societal implications’ of this study.  
 
Implications for the Patient - Provider Interface  
It seems unfortunate that with all the options available today 
with pharmacological treatment, patients have to still go 
through the game of try this, now that and let’s see what 
works! Since patients in this study were self selected, such Original Research  PHARMACY PRACTICE 
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that they could be more likely to adhere to their treatment, 
this study uncovered more provider or system related issues 
with depression treatment. All patients in this study wanted 
to stay on the medication they were on since they did not 
want to go through the process of starting depression 
treatment again, trying to choose the right drug and so on. 
However, they still had to go through a trial and error process 
before something worked for them.  
 
It would be logical to tailor medication information based on 
patient preferences. Especially since patients, like the 
students in this study would be likely to eventually tailor their 
medication to their bodily experience anyways. The effect of 
medication on emotions was also something that was seen as 
important for students in this study and it needs to be 
addressed by physicians since patients do react differently to 
the same effect depending on their priorities.  
 
As discussed earlier, the autonomy theme was interesting in 
that it provided a way for patients to probably not replace 
the provider but to have a collaborative relation and 
discussion with their provider regarding their treatment. 
Most of these patients wanted to be able to discuss 
treatment issues with their providers and some even came 
prepared with information from the internet and other 
sources to do so. However, almost all of the patients had not 
seen such a sentiment reciprocated by their providers.  
 
Some issues that were uncovered in this study that could 
potentially be addressed by physicians are related to the 
temporal aspect of patient medication taking and treatment 
decision making. Decision making role of some students in 
this study changed over time from wanting a remedy in their 
first visit to wanting to be a player in their treatment 
decisions in later visits. And patients’ need to be involved was 
evident as soon as they felt better after taking the 
antidepressant medication. While there were other patients 
who had both the ‘need for acknowledgement’ and ‘need to 
be a player’ right from the beginning of their treatment 
process for depression. This finding reiterates the findings of 
the study by Wills & Holmes- Rovner
29 where the authors 
when validating a decision scale in depressed patients found 
that decision satisfaction was associated with involvement in 
health related decisions.  
 
Another factor that made patients ‘ok’ with initiating and 
continuing antidepressants was that they had been told by 
their physicians that it was common to do so. Physicians 
discussing other patients in similar situations made patients 
feel at ease about their depression treatment. This sort of 
information can be easily incorporated even in a short patient 
visit. Overall, it is definitely important to balance and even 
start from the patient’s need for autonomy while providing 
expert advice at least in the case of college students’ 
depression treatment decision making.  
 
Implications for Pharmacy  
This study contributed to the understanding of 
antidepressant medication use in college students. Also, 
some implications specific to pharmacy practice were 
uncovered in this study. The most important one being that 
college students by virtue of their young age are ‘naïve’ to 
pharmacy since they may not be taking many prescription 
medications. Awareness needs to be created for students as 
to the availability of pharmacists as a resource in their health 
care. Being consistent with the idea of autonomy uncovered 
in this study, ultimately the patient will take the first step in 
seeking pharmacists for his or her medication related needs. 
  
Implications for Health Care System and College Systems  
Another finding that may be specific to college students and 
hence could be intervened upon was their unwillingness or 
inability to schedule counseling or therapy sessions. The 
reasons provided were varied the most common being ‘lack 
of time’. Also some of the other reasons were that these 
students did not like to be ‘put on the spot’ or did not see the 
usefulness of discussing their lives with psychologists.  
 
One option for college administrators would be to ‘convince’ 
students and allow them time in their schedules in some way 
to address their mental health and education through 
session(s) with psychologists. In fact, such mandatory 
sessions for all students may not be such a bad idea to enable 
college administrators to reduce the stigma of the process 
too! The second simpler solution would be to accept that 
students at the stage of their student career do not have time 
for therapy, and hence to further publicize availability of the 
antidepressant medication alternative to depression 
treatment.  
 
Regarding implications for the health care system overall, it is 
important to reduce barriers to mental health care as much 
as possible. The presidential commission report
30 on mental 
health called for a series of changes in the way mental illness 
is diagnosed and treated, where it was estimated that about 
$71 billion of the nation’s $1 trillion annual health care 
spending went for mental illness spending. The interesting 
distinction as pointed out by Michael Hogan, the chairman of 
the commission was that, “mental health is the only category 
where we spend more money not to treat it than to treat it”, 
referring to the money spent on disability claims due to this 
problem.  
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Earlier to the commission report, was the Institute of 
Medicine (IOM) report on ‘quality chasm’
31 wherein clearly 
systematic issues of ‘waste’ were described as a reason for 
increased costs. The report called for a “reduction of such 
waste and increase of efficiency through change in the 
microsystems of care where the ‘quality’ experienced by the 
patient is made or lost.” This report also called for moving 
from “professional autonomy to care customized according 
to the patients’ needs and values”.  
 
In the present study too, patient ‘autonomy’ was the 
essential theme for college students’ experience of 
depression treatment and decision making. Being prescribed 
a number of antidepressants without any attempt at 
‘customization’ led to not only ‘waste’, but also the patients’ 
dissatisfaction, distrust and eventually discontinuation of 
treatment. It does seem that today, there is definitely a need 
to reinforce and if needed enforce again the suggestions of 
the 2002 IOM report to be able to provide quality care. The 
next section goes on to describe the broader societal 
implications of the study findings.  
 
Societal Implications 
By examining the sociological aspect of depression and its 
treatment in addition to the psychological aspect one could 
get a more complete picture of the issue at hand. As 
discussed earlier, the students in this study did not have too 
many issues with the idea of taking antidepressants and most 
were ‘ok’ with taking them over a long period of time. This 
perception was different from other similar studies 
conducted in Denmark and Canada. Such differences could be 
possibly attributed to cultural differences in that the United 
States society and it’s perception of antidepressant use may 
be very different than that in Denmark or any other European 
country.  
 
In his book, ‘Better than Well’, author Carl Elliott
32 discusses 
the American obsession with enhancement technologies, 
saying that an antidepressant such as Prozac® is one such 
means that helps improve ‘self’ and hence despite the fear of 
medicalization has become commonplace in this society. The 
students’ comments in this study might be reflective of this 
societal perspective. There are some sociological issues 
inherent to the student population. For instance, when the 
students discussed their relations with their family, it was 
interesting to note that this ranged widely from the family 
being extremely supportive of their treatment to not even 
knowing about it.  
 
The family being supportive of treatment may not necessarily 
be a good thing since there may be some persons who might 
not be clinically depressed so as to need treatment. However, 
if the normal human experience of feeling down, anxious or 
lonely at times is ‘medicalized’ in this society it may be easier 
to follow that route for both parents and students. There has 
been enough discussion on this topic and books
31,33 have 
been written on such issues not only with regards to 
depression treatment but also other similar issues such as 
treating children for hyperactivity or treating anxiety in the 
earlier days. The medicalization of normal human experience 
at the same time trivializing medication use has been 
associated with persons minimizing their responsibilities to 
take care of themselves. However, in this study, medication 
seemed to act as a first ‘step’ that the students had to take 
before moving on to even thinking of taking care of 
themselves through other means.  
 
Speculating further on this, the breakdown of family structure 
and maybe even the culture of ‘consumerism’ added to the 
existing ‘individualism’ in today’s society, especially in the 
United States, might be some reasons why more and more 
college students or even adolescents or younger children are 
falling prey to such ‘dis-eases’ as depression. The other side 
of the issue is that general perception in the society that 
people are being unnecessarily medicated maybe a barrier to 
seeking care for those depressed persons who really need 
help and cannot function without it.  
 
Some students in this study felt that the antidepressant 
advertisements on television portrayed an ‘easy and quick 
solution’, which was misleading. Showing that depression is 
common may be good for reducing any societal stigma 
associated with having the disease. However it brings up the 
issue that patients may not be taken seriously precisely 
because the disease is so prevalent. In the end, although as 
researchers, we pick one aspect of a problem such as 
depression to study, it is necessary to keep in mind the bigger 
picture and its sociological impact. In the meantime, we can 
continue working towards improving the treatment of 
depression to at least take care of the present concern as 
best as we can. To conclude, we reiterate that ‘autonomy’ 
should be considered as a useful tool when focusing not only 
on depression treatment but the entire health care decision 
making for college students to provide them individualized 
and hence effective care.  
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Appendix I: Descriptive Information for Study Participants 
 
  Eight females, one male.  
  Age: 18-30 years, 7 of 9 were 25 years and below.  
  Diagnosis: Mild-severe depression, 5 of 9 had major or severe depression.  
  Length of illness: 6 weeks - 8 years, 5 of 9 had depression for 5 or more years.  
  Common co-morbidity: Anxiety  
  4 of 9 were prescribed Effexor®.  
  7 of 9 patients had been prescribed by a primary care physician.  
  All respondents had health insurance at beginning of study.  
 
 
 
 
Appendix II: Summary of Lifeworld Existentials Themes 
 
Lived Body  Lived Time  Lived Relation  Lived Space 
Antidepressant Use 
Trajectory: Different 
Effects at Initiation, 
Continuation and 
Discontinuation 
Developing Patience 
for Evaluating 
Antidepressants 
Patient View of 
Provider Role in 
Treatment Decisions: 
Physician and 
Psychologist Relations  
Creating a New Space: 
Being Open about 
having Depression 
Patient Role: A Player in 
Treatment Decisions  
Planning on Taking 
Antidepressants till 
No Stressors.  
Role of Friends and 
Family: Supportive but 
Not a Part of Decision 
Making  
 
Perceived Change in 
Existing Space: 
Everything is Really 
Normal 
 
Non Drug Steps to 
Reduce Depression 
Symptomology  
 
Looking for a ‘Quick 
Fix’  
Role of Others: 
Communal Relations  
 
Influence of 
Antidepressants: Isolated 
and Verbalized  
Taking Medications 
Everyday is Easy  
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Appendix III: Text Examples of Lifeworld Existentials 
 
Text Example of Lived Body:  
 
On usefulness of antidepressant medication:  
 
“Hmm, hmm. That’s what *Effexor®+ kind of made me seek out other people and find more friends and people to confide in so…ahm 
ya, but even knowing that I have more people to confide in and I have more friends that are accessible to me….that makes me feel 
better on it’s own. So it’ not completely the medication that did that……it’s kind of the medication helped me to do that…helped me 
to gain the self esteem and the confidence to meet more people. But because I did meet more people…… it’s helped me in 
confidence in ways that the medication you know, didn’t.”   
 
On concern with long term use of antidepressant medication: 
 
“I can’t really remember the last time I cried and before I did it a lot. I watched some really like sad movies lately and usually you 
know, I would cry over them, but it hasn’t really affected me lately so that kinda…so that kinda worries me like if something bad 
really happens and what if I don’t get affected and.. I don’t think that’s talked about enough, like, ya you’re going to be happy but 
never know what its like to be sad again.” 
 
Text Example of Lived Time:  
 
On planning to take antidepressants till less stress:  
 
“I don’t really know because I kind of want to see how my next situation is, with these residencies they are kind of a tense…and we 
have to do a lot of presenting and a lot of things that will cause a lot of anxiety and I don’t know if it would be good to decrease it at 
this time especially with the new change coming up and you know moving and starting the job and all these things. So I don’t…I 
don’t perceive it happening any time soon. It is kind of just you know when I feel stable enough with my life that I can decrease the 
medication and not worry about it. But I just don’t feel… I perceive too many changes happening that I don’t know if I would be able 
to handle it if I wasn’t on the medication.”  
 
On developing patience for antidepressant effect to take place: 
 
“I…… am surprised that the Effexor didn’t work very well for me but….. I guess I have always known that with this kind of thing with 
antidepressants and SSRIs is a little bit of art and a little bit of science and ahm….maybe I understand a little bit better now that you 
can’t expect it to be kind of a quantitative process that well you add this to this and this and then you are fine. It’s sort of a tinkering 
and I guess I have had to think about it with a little bit more patience but not really I mean, I perceive my depression as being 
something that I may have to live with my whole life and  I am ok with that and I think I can handle it so….” 
 
Text Example of Lived Relation:  
 
On describing experience with different physicians: 
 
“Like when I first went on Celexa it was like, ‘Oh Ya, you have depression Here *reference of previous physician+. And so I didn’t feel 
like he [refers to current physician] was pushing [the drug] on me, he was like you know what, are you sure you want to do that? 
Here are the different options. These are your side effects. Because of your history, you should try this one or you should try this one 
.I actually learned something about what I was going to be going on and I was able to ask questions. So, this was a lot more 
educational experience and I actually felt like he was there not just you know just checking his watch, like alright I have the next 
patient, so get out. That’s what I felt like with the first time. So having that experience *current+ where it seems they want to take 
the time and sit down with you and like figure out that this is something you need or just therapy is ok was really helpful, and like 
made me more ok with the decision I guess.” 
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On using friends as support system:  
 
“Ahm, I don’t talk with my family about it……just because you know, we don’t see eye to eye on certain things and my reason for 
doing it may not be their reason and I just don’t…. I just feel like it might bring up emotions and make me upset. I don’t feel like they 
would add to my getting better. But I do have a couple friends that have known about this like when it started, so I talk to them 
about it just to keep them up-to-date. Cause that way like you know if I don’t do something, I have someone to yell at me to be like, 
no do this, or like I am coming down to visit you to make sure that this happens and this doesn’t happen . So it’s really nice to have 
that support, you know outside of my providers.” 
 
Text Example of Lived Space:  
 
On creating new space to be helpful to others: 
 
“No, I think that it’s *antidepressant medication+ almost like it’s just a part of me now and I am not ashamed and I am not…..I have 
no problem… if one of my friends looks like they are having a hard time to give them advice or information about it. It’s just kind of a 
part of me now and it doesn’t have to be my whole life but right now I think that it is good for me to stay on it.” 
 
On perceiving change in existing space:  
 
“I’ve been feeling really good. I did not have a hard time coming back *to University+ which was really good, I was actually really 
excited to come back and start new classes and just be social with the people I have met. So ya, I had no problems coming back to 
Minneapolis. Ahm…..as far as school goes, I do still get stressed out about my grades and I always will. I don’t expect it to go away. 
It’s a healthy stress, its stress that makes me want to do well. But…ahm…relationships, personal relationships and stuff it’s……it’s 
been pretty stable, I mean I just kind of take things with a grain of salt and whatever comes of it, will come of it. So I never used to 
think like that, I would really overanalyze things and sometimes I still do overanalyze things but for the most part ahm…..everything 
is really normal.”  Original Research  PHARMACY PRACTICE 
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Appendix IV: Text Example of The Essential Theme – Autonomy 
 
On deciding to discontinue antidepressant due to distrust in provider:  
 
“Ahm….she *refers to physician+….at the time we talked about the drug and I said, what are the side effects and she said well you 
know you can get tired or you might get nervous. And I said specifically, does this drug cause weight gain? And she said no. And of 
course I am perfectly able to research things by myself and indeed Serzone does cause weight gain. So I lost trust in her with that 
and just stopped taking it [antidepressant+ because I didn’t want to gain weight and I didn’t like that she lied to me so…….I really 
didn’t like that she lied to me.”  
 
On describing importance of being the decision maker:  
 
“It’s important for me because….then I get a level of respect for her [physician] that she trusts me and she knows that I know what I 
am talking about and we are working together instead of me just going in and having her tell me what to do. Then I just… since it’s 
my body and my health care, I’d rather be the person making the decision with the physician. Even if it’s the dentist or someone 
where I don’t know much about, I rather still kind of make my own decisions and have them give me options just so…just because 
that’s my health. And I know…..so I can weigh all my options instead of just having them tell me what to do and my doing it without 
thinking.”  
 
 
 
 